B. Neuschwander‐Tetri
Epidemiology · 2000–2023
A researcher in the Science corpus: 12 papers; trusts 8 researchers and is trusted by 10 researchers here, as inferred from the citation graph.
Subfields
- Epidemiology — 131 citations into it; #358 of 2,148 by trust here, #145 by citations
- Hepatology — 50 citations into it
- Molecular Biology — 37 citations into it
- Physiology — 30 citations into it
Whom B. Neuschwander‐Tetri trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts B. Neuschwander‐Tetri overall
- N. Chalasani
- K. Cusi
- S. Friedman
- Z. Younossi
- V. Ratziu
- S. Bellentani
- E. Buzzetti
- M. Rinella
- E. Bugianesi
- J. Browning
Papers from B. Neuschwander‐Tetri's perspective
Ordered by how strongly the researchers B. Neuschwander‐Tetri trusts endorse each paper. Same corpus, a different order for every researcher.
- Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. (Gastroenterology)
- Fructose consumption as a risk factor for non-alcoholic fatty liver disease. (Journal of Hepatology)
- Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. (American Journal of Physiology. Endocrinology and Metabolism)
- Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. (Journal of Clinical Investigation)
- Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD). (Progress in lipid research)
- A lipidomic analysis of nonalcoholic fatty liver disease (Hepatology)
- Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease. (Gastroenterology)
- Autophagy regulates lipid metabolism (Nature)
- Free fatty acids promote hepatic lipotoxicity by stimulating TNF‐α expression via a lysosomal pathway
- Thematic review series: Adipocyte Biology. The perilipin family of structural lipid droplet proteins: stabilization of lipid droplets and control of lipolysis Published, JLR Papers in Press,… (Journal of Lipid Research)
Their papers
- Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR‐γ ligand rosiglitazone (2003) — 766 citations
- AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease (2023) — 1,742 citations
- Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease (2021) — 821 citations
- Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. (2019) — 617 citations
- Mechanisms of NAFLD development and therapeutic strategies (2018) — 3,682 citations
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial (2014) — 2,063 citations
- Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings (2011) — 1,153 citations
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis (2010) — 3,032 citations
- Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites (2010) — 1,037 citations
- Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease (2008) — 843 citations
- Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference (2003) — 2,251 citations
- Humanized xenobiotic response in mice expressing nuclear receptor SXR (2000) — 696 citations